LOGIN
Leukocyte-Poor Platelet-Rich Plasma For Arthroscopic Rotator Cuff Repair
October 2024
Leukocyte-Poor Platelet-Rich Plasma For Arthroscopic Rotator Cuff Repair
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Leukocyte-Poor Platelet-Rich Plasma as an Adjuvant to Arthroscopic Rotator Cuff Repair Reduces the Retear Rate But Does Not Improve Functional Outcomes: A Double-Blind Randomized Controlled Trial.
Am J Sports Med . 2024 May;52(6):1403-1410.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety-six patients with rotator cuff tears smaller than 3 cm were randomized to receive either arthroscopic rotator cuff repair (ARCR) with leukocyte-poor platelet-rich plasma (LP-PRP) injection (n=48) or ARCR without PRP (n=48). The primary outcome was the retear rate, assessed via MRI at six months. Secondary outcomes included pain (VAS), functional scores (ASES, SANE), and sleep quality (PSQI)...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.